S Ananth Karumanchi Selected Research

Lipocalin-2

1/2016	Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep Apnea.
11/2006	Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells.
4/2005	Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Ananth Karumanchi Research Topics

Disease

133	Pre-Eclampsia (Preeclampsia) 04/2024 - 03/2003
36	Hypertension (High Blood Pressure) 01/2024 - 03/2003
20	Proteinuria 01/2024 - 03/2003
10	Inflammation (Inflammations) 03/2024 - 10/2008
10	Neoplasms (Cancer) 12/2018 - 01/2002
8	Hypoxia (Hypoxemia) 01/2019 - 10/2004
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 11/2009
7	Acute Kidney Injury (Acute Renal Failure) 07/2020 - 08/2012
6	Heart Failure 04/2024 - 09/2011
6	Chronic Renal Insufficiency 03/2024 - 02/2010
6	Ischemia 10/2022 - 02/2010
6	Vascular Remodeling 01/2020 - 07/2009
6	Hemolysis 08/2019 - 06/2006
6	Fibrosis (Cirrhosis) 01/2019 - 06/2012
6	Sepsis (Septicemia) 11/2012 - 03/2006
5	Delirium 11/2022 - 10/2021
5	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2022 - 03/2011
5	Edema (Dropsy) 08/2017 - 02/2008
5	Eclampsia 08/2012 - 07/2006
5	Endotoxemia 10/2011 - 06/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 02/2009
4	Vitamin D Deficiency 01/2021 - 09/2011
4	HELLP Syndrome 08/2019 - 01/2007
4	Neoplasm Metastasis (Metastasis) 12/2018 - 04/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 01/2007
4	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 10/2014 - 02/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 07/2011 - 01/2002
3	Insulin Resistance 04/2024 - 05/2004
3	Body Weight (Weight, Body) 03/2024 - 01/2011
3	Anemia 01/2023 - 02/2010
3	Fetal Death 01/2022 - 11/2009
3	Lung Injury 10/2021 - 06/2011
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 03/2007
3	Birth Weight (Birth Weights) 07/2020 - 07/2004
3	Thrombocytopenia (Thrombopenia) 01/2018 - 05/2010
3	Obesity 01/2017 - 07/2010
3	Perinatal Death 07/2016 - 08/2012
3	Kidney Diseases (Kidney Disease) 11/2014 - 09/2010
2	Atherosclerosis 03/2024 - 11/2014
2	Premature Obstetric Labor (Premature Labor) 01/2023 - 01/2012
2	Aneuploidy (Aneuploid) 11/2022 - 04/2013
2	Uremia 01/2022 - 01/2015
2	Acute Lung Injury 01/2022 - 01/2022
2	Cognitive Dysfunction 10/2021 - 10/2021
2	Infections 01/2021 - 11/2012
2	Placenta Accreta 01/2020 - 01/2020
2	Hemolytic-Uremic Syndrome 08/2019 - 02/2012
2	Thyroid Neoplasms (Thyroid Cancer) 12/2018 - 10/2017
2	Cardiomegaly (Heart Hypertrophy) 01/2017 - 09/2011

Drug/Important Bio-Agent (IBA)

60	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2023 - 03/2003
44	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2024 - 03/2003
32	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2019 - 03/2003
31	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2004
31	EndoglinIBA 01/2019 - 06/2006
21	Biomarkers (Surrogate Marker)IBA 06/2023 - 09/2006
19	Tyrosine (L-Tyrosine)FDA Link 01/2024 - 10/2005
18	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2022 - 02/2004
13	Angiogenic ProteinsIBA 10/2016 - 06/2005
10	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 08/2005
9	EnzymesIBA 07/2020 - 06/2006
9	CalciumIBA 01/2017 - 02/2004
8	Vitamin D FDA LinkGeneric 01/2021 - 11/2009
7	AlbuminsIBA 01/2023 - 03/2007
6	LigandsIBA 03/2024 - 12/2007
6	Interleukin-6 (Interleukin 6)IBA 11/2022 - 02/2010
5	CytokinesIBA 03/2024 - 02/2010
5	Complement System Proteins (Complement)IBA 01/2022 - 09/2010
5	Messenger RNA (mRNA)IBA 01/2020 - 08/2005
5	Uric Acid (Urate)IBA 02/2009 - 02/2004
4	Oxygen (Dioxygen)IBA 01/2022 - 01/2002
4	CreatinineIBA 12/2016 - 03/2007
4	AldosteroneIBA 02/2014 - 01/2011
3	Hemoglobins (Hemoglobin)IBA 03/2024 - 11/2013
3	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 12/2004
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2023 - 02/2014
3	SaltsIBA 01/2023 - 09/2011
3	Blood Proteins (Serum Proteins)IBA 01/2023 - 04/2013
3	AntioxidantsIBA 01/2019 - 12/2011
3	Angiopoietin-2IBA 01/2019 - 03/2006
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2018 - 06/2009
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018 - 04/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 12/2010
3	Erythropoietin FDA Link 02/2017 - 02/2010
3	Lipocalin-2IBA 01/2016 - 04/2005
3	LeptinIBA 11/2011 - 07/2010
3	AntibodiesIBA 10/2008 - 06/2006
2	activin AIBA 04/2024 - 01/2018
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 05/2017
2	VemurafenibIBA 12/2018 - 10/2017
2	FibrinIBA 08/2017 - 06/2016
2	Phosphotransferases (Kinase)IBA 11/2016 - 05/2012

Therapy/Procedure

23	Therapeutics 05/2021 - 01/2002
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2021
3	Renal Dialysis (Hemodialysis) 02/2017 - 11/2009
3	Ligation 01/2016 - 10/2008
2	Hysterectomy 01/2020 - 01/2014
2	Glycemic Control 02/2017 - 02/2014